When will silver crumbs use biological agents?
Silver crumb is a chronic, regenerative, inflammatory, systemic disease induced by genetic and environmental co-effects, typically clinically manifested in crumbs or clots, limited or widely distributed, non-transmissible, difficult to treat and often lifelong. Biological agents, as a new treatment, show significant results in the treatment of silver crumbs. So, under what circumstances should people with silver crumbs consider using biological agents?
I. APPLICATION OF DISAPPEARANCES
1. **Medium severe silver crumb** – Patients have a rash area of more than three hands of their own size or PASI was diagnosed by a doctor as > 10. – Normal, suspense-type, red skin-type silver crumbs, as well as incurable skin-deprecating patients, such as those with poor or vulnerable external medication in the palm, sole, face, genital organs, etc.
2. ** Combined silver crumb arthritis** – Patients suffer from disorders such as joint pain and rheumatologists may consider using biological agents for treatment.
The timing of treatment The time of use of biological agents by persons with silver crumbs varies from individual to individual, usually between weeks and months. The effect of treatment and the activity of the condition are the main factors affecting the length of treatment. – ** Low-morbid and non-serious combinations**: At this point in time, the use of biological agents is more effective and can effectively control the condition and reduce relapse. – ** Severe or incurable silver crumbs**: due to the complexity of the condition, it may require longer treatment to achieve optimal results. -** There is a syndrome**: in the case of cardiovascular diseases, treatment may need to be extended to reduce risk.
At present, the types of biological agents used to treat silver crumbs consist mainly of the following categories:
1. **TNF-α inhibitor**: Innasip, reduce inflammation by inhibiting TNF-α activity.
2. **IL-12/23 inhibitor**: if ussunu resists, it regulates the immune response and reduces the symptoms of silver crumbs.
3. **IL-17A inhibitor **: If Succhiyo is single, IL-17A can be cut off from receptors on the surface of the cell, thereby reducing skin inflammation.
4. ** Other biological agents**: for example, Ardaki, Injecting Inflicisi, etc., contain inflammation responses through different mechanisms to improve skin skin loss from silver crumbs.
IV. NOTES
1. **Studential guidance**: The use of biological agents needs to be conducted under the guidance of a specialist, and appropriate treatments are selected on an individual basis.
2. ** Surveillance of the condition**: During treatment with biological agents, the patient ‘ s activity and cogeneration should be closely monitored and the treatment programme adjusted in a timely manner.
3. ** Adverse effects**: Biological agents may cause a number of adverse effects, such as pain, headaches, nausea, etc., in the injection area, and patients should be fully informed and treated under medical guidance. In the light of the above, when the conditions for the use of biological agents are met by persons suffering from silver crumbs, appropriate treatments should be selected on an individual basis, under the guidance of a specialist. At the same time, patients should maintain good living habits, take care to keep their skin clean and wet and avoid the use of irritating soap to bathe in order to reduce the risk of increased illness.
